BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25591797)

  • 1. Diphenylene iodonium interferes with cell cycle progression and induces apoptosis by modulating NAD(P)H oxidase/ROS/cell cycle regulatory pathways in Burkitt's lymphoma cells.
    Ding Y; Zhu W; Sun R; Yuan G; Zhang D; Fan Y; Sun J
    Oncol Rep; 2015 Mar; 33(3):1434-42. PubMed ID: 25591797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMP1 Increases Expression of NADPH Oxidase (NOX) and Its Regulatory Subunit p22 in NP69 Nasopharyngeal Cells and Makes Them Sensitive to a Treatment by a NOX Inhibitor.
    Sun J; Hu C; Zhu Y; Sun R; Fang Y; Fan Y; Xu F
    PLoS One; 2015; 10(8):e0134896. PubMed ID: 26244812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apogossypolone induces reactive oxygen species accumulation and controls cell cycle progression in Raji Burkkit's lymphoma cells.
    Hu ZY; Xu F; Sun R; Chen YF; Zhang DS; Fan YH; Sun J
    Mol Med Rep; 2015 Jul; 12(1):337-44. PubMed ID: 25738577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
    D'Souza B; Rowe M; Walls D
    J Virol; 2000 Jul; 74(14):6652-8. PubMed ID: 10864681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression.
    Yamaura M; Mitsushita J; Furuta S; Kiniwa Y; Ashida A; Goto Y; Shang WH; Kubodera M; Kato M; Takata M; Saida T; Kamata T
    Cancer Res; 2009 Mar; 69(6):2647-54. PubMed ID: 19276355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
    Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
    Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NADPH oxidase inhibitor DPI can abolish hypoxia-induced apoptosis of human kidney proximal tubular epithelial cells through Bcl2 up-regulation via ERK activation without ROS reduction.
    Song H; Han IY; Kim Y; Kim YH; Choi IW; Seo SK; Jung SY; Park S; Kang MS
    Life Sci; 2015 Apr; 126():69-75. PubMed ID: 25744050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma.
    Shin DY; Kim A; Kang HJ; Park S; Kim DW; Lee SS
    Cancer Lett; 2015 Aug; 364(2):89-97. PubMed ID: 25790907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylbutyrate induces cell differentiation and modulates Epstein-Barr virus gene expression in Burkitt's lymphoma cells.
    Bar-Ner M; Thibault A; Tsokos M; Magrath IT; Samid D
    Clin Cancer Res; 1999 Jun; 5(6):1509-16. PubMed ID: 10389940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells.
    Mochizuki T; Furuta S; Mitsushita J; Shang WH; Ito M; Yokoo Y; Yamaura M; Ishizone S; Nakayama J; Konagai A; Hirose K; Kiyosawa K; Kamata T
    Oncogene; 2006 Jun; 25(26):3699-707. PubMed ID: 16532036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Epstein-Barr virus in Burkitt's lymphoma.
    Takada K
    Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways.
    Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG
    J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.
    Cen O; Longnecker R
    Mol Cancer Ther; 2011 Apr; 10(4):679-86. PubMed ID: 21282357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.